PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · IEX Real-Time Price · USD
2.020
+0.060 (3.06%)
Jul 22, 2024, 9:33 AM EDT - Market open
PharmaCyte Biotech Employees
PharmaCyte Biotech had 2 employees as of April 30, 2023. The number of employees decreased by 2 or -50.00% compared to the previous year.
Employees
2
Change (1Y)
-2
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$5,753,842
Market Cap
17.08M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
China Jo-Jo Drugstores | 938 |
BIMI International Medical | 296 |
VBI Vaccines | 138 |
Talis Biomedical | 99 |
Kindly MD | 65 |
Sensei Biotherapeutics | 28 |
Microbot Medical | 22 |
Chemomab Therapeutics | 20 |
PMCB News
- 2 months ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire
- 2 months ago - PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - Business Wire
- 8 months ago - PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc. - Business Wire
- 9 months ago - PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology - Business Wire
- 1 year ago - PharmaCyte Biotech Announces Final Results of Tender Offer - Business Wire
- 1 year ago - PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share - Business Wire
- 1 year ago - PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan - Business Wire
- 1 year ago - PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value - GlobeNewsWire